KYNU
protein-codingkynureninase
Gene summary
Kynureninase is a pyridoxal-5'-phosphate (pyridoxal-P) dependent enzyme that catalyzes the cleavage of L-kynurenine and L-3-hydroxykynurenine into anthranilic and 3-hydroxyanthranilic acids, respectively. Kynureninase is involved in the biosynthesis of NAD cofactors from tryptophan through the kynurenine pathway. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~178.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0060555
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0060555
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009372
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0009372
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009372
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0060555
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0020831
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009372
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0060555
Submitter: ClinGen
*KYNU* was first reported in relation to autosomal recessive vertebral, cardiac, renal, and limb defects syndrome 2 in 2017 (Shi H, et al., 2017, PMID: 28792876) but was previously identified with hydroxykynureninuria in 2007 (Christensen M, et al., 2007, PMID: 17334708). Congenital defects found in VCRL2 include segmentation defects, cardiac defects such as hypoplastic heart, hypoplastic kidneys, missing kidneys, clinodactyly, radial deviation, and polydactyly. Evidence supporting this gene-disease relationship includes case-level data and experimental data. At least 14 unique variants (e.g. missense, nonsense, frameshift, splicing, and large deletion) have been reported in 11 probands from 5 publications (PMIDs: 28792876, 33942433, 31923704, 17334708, 34200361). Variants in this gene segregated with disease in 1 additional family member. The gene *KYNU* encodes Kynureninase, one of the enzymes responsible for the biosynthesis of NAD from Trpytophan. This gene-disease association is further supported by its biochemical function in the kynurenine pathway (PMID: 8706755) and a knockout mouse model (PMID: 28792876) which recapitulates the phenotype on a NAD-restricted diet. In summary, *KYNU* is definitively associated with autosomal recessive vertebral, cardiac, renal, and limb defects syndrome 2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the Aminoacidopathy GCEP on 07/10/2020. It was reevaluated on 08/01/2022. As a result of this reevaluation, the classification increased from Moderate to Definitive with the addition of 5 new cases (PMIDs: 33942433 and 34200361).
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Musculoskeletal; Renal
Intervention: Cardiovascular
Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early identifcation and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KYNU variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003937.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 9 | 3 | 13 | ||
| missense | 3 | 6 | 72 | 5 | 1 | 87 |
| nonsense | 1 | 5 | 1 | 7 | ||
| start loss | 0 | |||||
| frameshift | 7 | 7 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 4 | 5 | 11 | ||
| Total | 6 | 22 | 79 | 14 | 4 | 125 |
Highest pathogenic variant AF is 0.00015750766
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003928.1 | 13 | MANE Select | |
| Ensembl | ENSP00000264170.4 | 13 | MANE Select | |
| RefSeq | NP_001028170.1 | 10 | Standard | |
| RefSeq | NP_001186170.1 | 13 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Tryptophan metabolism - Homo sapiens (human)
- Tryptophan Metabolism
- Selenium Micronutrient Network
- NAD Biosynthesis II (from tryptophan)
- Tryptophan metabolism
Biological Process
- tryptophan catabolic process
- aging
- NAD biosynthetic process
- tryptophan catabolic process to kynurenine
- tryptophan catabolic process to acetyl-CoA
Molecular Function
- pyridoxal phosphate binding
- kynureninase activity
- protein homodimerization activity
- 3-hydroxykynureninase activity
Cellular Component
- nucleoplasm
- mitochondrion
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000264170
- Coding exons
- 13
- Length
- 164824
- Individuals with no LoFs
- 125573
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 175
- Defined
- 125748
- p
- 0.000696
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.413 | 267 | 249 | 1.07 | 0.0000126 | 3032 |
| Missense (PolyPhen) | 93 | 95.641 | 0.97239 | 1068 | ||
| Synonymous | 0.829 | 79 | 88.9 | 0.888 | 0.00000456 | 878 |
| Loss of Function | 0.0902 | 27 | 27.5 | 0.981 | 0.00000151 | 333 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00094 | 0.00092 | rare |
| Latino/Admixed American | 0.00022 | 0.00020 | rare |
| Ashkenazi Jewish | 0.00033 | 0.00030 | rare |
| East Asian | 0.00065 | 0.00065 | rare |
| Finnish | 0.00038 | 0.00037 | rare |
| European (Non-Finnish) | 0.0010 | 0.00098 | notable |
| South Asian | 0.00050 | 0.00046 | rare |
| Other | 0.00086 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3- hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3- hydroxyanthranilic acid (3-OHAA), respectively. Has a preference for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase activity. {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176, ECO:0000269|PubMed:28792876, ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.;
- Disease
- DISEASE: Hydroxykynureninuria (HYXKY) [MIM:236800]: An inborn error of amino acid metabolism characterized by massive urinary excretion of large amounts of kynurenine, 3-hydroxykynurenine and xanthurenic acid. Affected individuals manifest renal tubular dysfunction, metabolic acidosis, psychomotor retardation, non- progressive encephalopathy, and muscular hypertonia. {ECO:0000269|PubMed:17334708, ECO:0000269|PubMed:28792876}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Vertebral, cardiac, renal, and limb defects syndrome 2 (VCRL2) [MIM:617661]: An autosomal recessive congenital malformation syndrome characterized by vertebral segmentation abnormalities, congenital cardiac defects, renal defects, and distal mild limb defects. {ECO:0000269|PubMed:28792876}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- LoFtool
- 0.539
- RVIS EVS
- -0.6
- RVIS percentile EVS
- 18.06
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.876
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |